Two to buy
CVS
(Investors Chronicle) Britain’s largest veterinary-services company operates more than 500 practices. Levels of pet ownership have risen steadily over the last ten years and “rocketed” under lockdown. The number of insured pets has risen too, which will “help to protect CVS’s income in an economic downturn”. The reopening of its small-animal sites has boosted sales. The forward price/earnings ratio of 23 does not fully reflect the company’s potential. 1,205p
DFS Furniture
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
(The Times) People forced by the pandemic to stay at home are “using their spare cash to make their homes and gardens... a bit smarter or... a bit more bearable”. That has bolstered the home-improvement sector. Sofa retailer DFS is a “post-lockdown winner”, with orders worth £70m in the six weeks since it reopened its stores. It is expected to make adjusted profits of £80m next year on sales of £1bn. 170p
Two to sell
Just Eat Takeaway
(The Times) “The world’s largest food delivery company outside China” did well out of Covid-19. Sales jumped by 44% in the first half, but pre-tax losses widened. They may widen further now that the firm is building its own distribution network to keep pace with Deliveroo and other rivals – an expensive undertaking, especially in the US. Just Eat should survive the industry’s “shakeout”, but the shares are overvalued given the “unappetising” outlook. Avoid. 8,706p
Micro Focus
(Investors Chronicle) Once Britain’s biggest technology group, this collector of software assets came unstuck in 2017 when it bought Hewlett Packard Enterprise’s software business. The move cost Micro Focus $8.8bn, doubling the debt load to three times its market capitalisation and triggering a goodwill impairment charge of $960m over three years. Competition is “fierce” and a recovery looks unlikely. Sell. 296p
...and the rest
Investors Chronicle
AB Dynamics, “a ‘one-stop testing shop’ for the global automotive industry”, is priced at a premium. But a strong predicted recovery and regulatory tailwinds make it worth buying (1,735p). Investment platform provider Nucleus Financial is a “decently priced growth stock” (130p).
The Daily Telegraph
Online gaming operator Gamesys has delivered on expectations and “there could be further gains to come”. Hold (£11.20). Matthew Dobbs, the manager of the Schroder AsiaPacific Fund, will be missed when he retires. “We will hold, but monitor progress” (491p).
Shares
Despite navigating the pandemic “impressively”, UP Global Sourcing, the consumer-brands firm behind Salter weighing scales, remains a bargain (94p). Hold on to shares in LED lighting company Luceco, even though they have “gone bananas” (187p).
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
MoneyWeek is written by a team of experienced and award-winning journalists, plus expert columnists. As well as daily digital news and features, MoneyWeek also publishes a weekly magazine, covering investing and personal finance. From share tips, pensions, gold to practical investment tips - we provide a round-up to help you make money and keep it.
-
Can the gold price rise to $6,000?Gold prices have made dramatic jumps early in 2026. Can gold keep rising, or is it becoming a victim of its own success?
-
The coastal locations where properties are losing valueProperty prices across a number of coastal hotspots plunged in 2025 - which areas are most affected?
-
Three promising emerging-market stocks to diversify your portfolioOpinion Omar Negyal, portfolio manager, JPMorgan Global Emerging Markets Income Trust, highlights three emerging-market stocks where he’d put his money
-
Coface offers excess profit in an unloved sectorCoface is a world leader in trade-credit insurance with key competitive advantages in a niche market
-
Exciting opportunities in biotechBiotech firms should profit from the ‘patent cliff’, which will force big pharmaceutical companies to innovate or make acquisitions
-
How to invest in the new breed of payment providersUpstart payment providers are taking the world by storm. It’s time for investors to buy in, says Rupert Hargreaves
-
What turns a stock market crash into a financial crisis?Opinion Professor Linda Yueh's popular book on major stock market crashes misses key lessons, says Max King
-
How to add cryptocurrency to your portfolioA new listing shows how bitcoin might add value to a portfolio if cryptocurrency keeps gaining acceptance, says Cris Sholto Heaton
-
Profit from pest control with Rentokil InitialRentokil Initial is set for global expansion and offers strong sales growth
-
Three funds to buy for capital growth and global incomeOpinion Three investment trusts with potential for capital growth, selected by Adam Norris, co-portfolio manager of the CT Global Managed Portfolio Trust
